Thrombophilia screening in young patients with cryptogenic stroke: Prevalence of gene polymorphisms compared to healthy blood donors and impact on secondary stroke prevention

Hamostaseologie

Volumn 32, Issue 2, 2012, Pages 147-152

  Häusler, Karl Georg ^a   Herm, J ^a   Hoppe, B ^a   Kasabov, R ^a   Malzahn, U ^a   Endres, M ^a   Koscielny, J ^a   Jungehulsing, G J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

FVII R353Q mutation; Genetics; Ischaemic stroke; Secondary stroke prevention

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC SCREENING; HOSPITAL DISCHARGE; HUMAN; MALE; PREVALENCE; RETROSPECTIVE STUDY; THROMBOPHILIA; AGED; COMORBIDITY; GENETIC PREDISPOSITION; GENETICS; GERMANY; MASS SCREENING; MIDDLE AGED; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS; STROKE;

ADULT; AGED; BLOOD DONORS; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; REFERENCE VALUES; STROKE; THROMBOPHILIA; YOUNG ADULT;

EID: 84866181961     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.5482/ha-1175     Document Type: Article

References (33)

1. Adams HP. Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
2. Adamski MG, Turaj W, Slowik A et al. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease. Acta Neurol Scand 2009;120:94-100.
3. Austin H. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke 2002;33:2762-2768.
4. Casas JP, Hingorani AD, Bautista LE et al. Metaanalysis of genetic studies in ischemic stroke: thirtytwo genes involving approximately 18 000 cases and 58 000 controls. Arch Neurol 2004;61:1652-1661.
5. Celiker G, Can U, Verdi H et al. Prevalence of thrombophilic mutations and ACE I/D polymorphism in Turkish ischemic stroke patients. Clin Appl Thromb Hemost 2011;15:415-420.
6. Chen CH, Lo YK, Ke D et al. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese. J Neurol Sci 2004;227:1-5.
7. Diener HC, Putzki N. Akuttherapie des ischämischen Schlaganfalls. In: Diener HC, Putzki N (Hrsg). Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme 2008;654ff.
8. Fernández-Cadenas I, Molina CA, Alvarez-Sabín J et al. ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke. Neurosci Lett 2006;398:167-171.
9. Galli M, Luciani D, Bertolini G et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphos-pholipid syndrome: a systematic review of the literature. Blood 2003;101:1827-1832.
10. Guercini F, Acciarresi M, Agnelli G et al. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost 2008;6:549-554.
11. Hankey GJ, Eikelboom JW. Editorial comment-Routine thrombophilia testing in stroke patients is unjustified. Stroke 2003;34:1826-1827.
12. Hennerici MG. Diagnostik zerebrovaskulärer Er-krankungen. In: Diener H, Putzki N, Berlit P (Hrsg). Leitlinien für Diagnostik und Therapie in der Neuro logie. Stuttgart: Theime 2008.
13. Heywood D, Carter A, Catto A, et al. Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 1997;28:816-821.
14. Hoppe B, Tolou F, Dörner T et al. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population. Thromb Haemost 2006;96:465-470.
15. Iacoviello L, Di Castelnuovo A, De Knijff P et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1988;338:79-85.
16. Jungehulsing GJ, Nolte CH. Prothrombotic gene variations in ischemic stroke: no differences between large and small vessel disease? Neuroepidemiology 2008;31:282.
17. Junker R, Glahn J, Tidow N. The tissue factor pathway inhibitor C536T mutation is not associated with the risk of stroke in young adults. Thromb Haemost 2002;87:920-921.
18. Kleesiek K, Schmidt M, Götting C et al. The 536C→T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis. Thromb Haemost 1999;82:1-5.
19. Kolominsky-Rabas PL, Weber M, Gefeller O et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735-2740.
20. Levine SR, Brey RL, Tilley BC et al. Antiphospho-lipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004;291:576-584.
21. Lichy C, Stoll F, Kropp S et al. Cerebral ischemia in young adults and genetic polymorphisms of coagulation factors II, V and VII. Thromb Haemost 2004;91:825-827.
22. Lopaciuk S, Windyga J, Watala CW et al. Polymorphisms in the factor VII gene and ischemic stroke in young adults. Blood Coagul Fibrinolysis 2010;21:442-447.
23. Morris JG, Singh S, Fisher M. Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke 2010;41:2985-2990.
24. Pötzsch B, Madlener K. Hämostaseologie. Heidelberg: Springer 2010.
25. Reiner AP, Kumar PN, Schwartz SM et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000;31:1628.
26. Rosendaal FR, Siscovick DS, Schwartz SM et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817-2821.
27. Shemirani AH, Pongrácz E, Antalfi B et al. Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke. Thromb Res 2010;126:159-162.
28. Siegerink B, Rosendaal FR, Algra A. Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost 2009;7:385-390.
29. Tan Q, Tang H, Liu R, et al. Marburg I polymorphism of factor VII-activating protease and cerebral infarction. Zhong nan da xue xue bao 2009;34:1171-1175.
30. Weber R, Busch E. Thrombophilien bei Patienten mit ischämischem Schlaganfall. Nervenarzt 2005;76:193-201.
31. Weber R, Goertler M, Benemann J et al. Prognosis after cryptogenic cerebral ischemia in patients with coagulopathies. Cerebrovas Dis 2009;28:611-617.
32. Wypasek E, Stepien E, Pieculewicz M et al. Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale. Thromb Haemost 2009;102:1280-1282.
33. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 2005;37:413-417.